only with


Neuland Laboratories Ltd.
Neuland Laboratories
Neuland Laboratories Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹255.86 Cr.
| EX-Date | Purpose |
|---|---|
| 11 05 2021 | Final Dividend & Audited Results |
| 03 08 2021 | Quarterly Results |
| 29 10 2021 | Quarterly Results |
| 01 02 2022 | Quarterly Results |
| 10 05 2022 | Final Dividend & Audited Results |
| 03 08 2022 | Quarterly Results |
| 10 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 11 05 2023 | Audited Results & Final Dividend |
| 03 08 2023 | Quarterly Results |
| 07 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 06 11 2024 | Quarterly Results |
| 10 02 2025 | Quarterly Results |
| 15 05 2025 | Quarterly Results & Final Dividend |
| 31 07 2025 | Quarterly Results |
| 07 11 2025 | Quarterly Results |
| 09 02 2026 | Quarterly Results |
| 12 05 2026 | Quarterly Results & Final Dividend |
| 05 08 2026 | Quarterly Results |
News
Neuland Labs starts operations at first commercial peptide manufacturing module
Module one provides 7,000 L total reactor capacity, 750 L of solid-phase peptide synthesis and 6,250 L liquid-phase peptide synthesis
Neuland Laboratories informs about press release
Neuland Lab surges as its Board approves Rs 126 crore capex
The capex is towards the purchase of around 134 acres of land situated at Kakinada, Andhra Pradesh
Neuland Lab’s Board approves Rs 126 crore capex
The capex is towards the purchase of around 134 acres of land situated at Kakinada, Andhra Pradesh
USFDA inspects Neuland Laboratories’ manufacturing facility in Telangana
At the conclusion of the inspection, the USFDA issued a Form 483 with one observation.
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 1473.62 Mln, in the June 2026 quarter
Neuland Laboratories informs about newspaper publication
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about investor meetings
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 2125.23 Mln, in the March 2026 quarter
Neuland Laboratories submits earnings call intimation
Neuland Laboratories informs about press release
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 404.17 Mln, in the December 2025 quarter
Neuland Laboratories informs about analyst meet
Neuland Laboratories informs about analyst meet
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about analyst meet
Neuland Laboratories informs about re-lodgement of transfer requests of physical shares
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 964.60 Mln, in the September 2025 quarter
Neuland Laboratories informs about earnings call
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about loss of share certificate
Neuland Laboratories informs about newspaper publication
Neuland Laboratories reports Profit after tax of Rs 137.08 Mln, in the June 2025 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about credit rating
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about issuance of letter of confirmation
Neuland Laboratories informs about analyst meet
Neuland Laboratories approves dividend
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 277.34 Mln, in the March 2025 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about earnings call
USFDA inspects Neuland Laboratories’ Unit 2 manufacturing facility in Telangana
The FDA issued Form 483, with one observation related to building and facility management
Neuland Laboratories informs about board meeting
Neuland Laboratories informs about disclosure
Neuland Laboratories informs about disclosure
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 1013.94 Mln, in the December 2024 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories leads the gainers of group A on BSE
The other top gainers of group ‘A’ on the BSE were Bajaj Holdings & Investment up by 4.17%, South Indian Bank up by 3.72% and Multi Commodity Exchange of India was up by 3.31%
Neuland Laboratories informs about certificate
Neuland Laboratories informs about updates
Neuland Laboratories informs about disclosure
Neuland Laboratories informs about disclosure
Neuland Laboratories informs about investor meet
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about press release
Neuland Laboratories reports Profit after tax of Rs 319.59 Mln, in the September 2024 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about certificate
Neuland Laboratories informs about details of loss of certificate
Neuland Laboratories informs about certificate
Neuland Laboratories informs about certificate
Neuland Laboratories informs about analyst meet
Neuland Laboratories informs about issuance of letter of confirmation
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 807.01 Mln, in the December 2023 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about transcript of earnings call
Neuland Laboratories reports Profit after tax of Rs 890.65 Mln, in the September 2023 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about loss of share certificate(s)
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 622.24 Mln, in the June 2023 quarter
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories informs about newspaper publication
Neuland Laboratories informs about analyst meet
USFDA completes inspection at Unit 3 manufacturing facility of Neuland Laboratories
The inspection has been concluded with 3 observations (minor) given under form 483
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories reports Profit after tax of Rs 845.10 Mln, in the March 2023 quarter
Neuland Laboratories submits analyst meet intimation
Neuland Laboratories informs about disclosure
Neuland Laboratories informs about newspaper advertisement
Neuland Laboratories - Quaterly Results
Neuland Laboratories - Quaterly Results
Neuland Laboratories informs about analyst meet
Neuland Laboratories informs about voting result of the remote e-voting and scrutinizer’s report
Neuland Laboratories informs about issuance of letter of confirmation
Neuland Laboratories gets nod to transfer Telangana property to various parties
The Board of Directors at their meeting held on November 23, 2022, has approved the same

